EX-23 2 vrca-ex23_1.htm EX-23.1 EX-23

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

 

 

The Board of Directors

Verrica Pharmaceuticals Inc.:

 

 

We consent to the incorporation by reference in the registration statements (Nos. 333-226153, 333-231265, 333-237174, 333-255919 and 333-264784) on Form S-8 and (No. 333-268229) on Form S-3 of our report dated March 6, 2023, with respect to the financial statements of Verrica Pharmaceuticals Inc.

 

/s/ KPMG LLP

Philadelphia, Pennsylvania
March 6, 2023